latanoprostene bunod
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
9 FDA-registered drug labelers
Assia Chemical Industries Ltd - Teva Tech Site
Bausch & Lomb Incorporated
Cayman Pharma s.r.o.
EUROAPI Hungary Ltd.
Everlight Chemical Industrial Corporation Kuanyin II Plant
Gland Pharma Limited
MSN Laboratories Private Limited
YS Life Science Co., Ltd.
Zhejiang Ausun Pharmaceutical Co., Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 2 drug and cosmetic product listings (FDA).
- •Latanoprostene Bunod Ophthalmic Solution, 0.024%
- •Vyzulta
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS860005-21-6
PubChem CID11156438
DTXSIDDTXSID101027765
FormulaC27H41NO8
Mol. Weight507.6 g/mol
SMILESC1C(C(C(C1O)CC=CCCCC(=O)OCCCCO[N+](=O)[O-])CCC(CCC2=CC=CC=C2)O)O
Data Sources
111564382026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/latanoprostene bunod/cids/JSON
Archive: data/sources/pubchem_name/latanoprostene bunod.json
CAS 860005-21-62026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json